POST-MARKETING STUDY OF THE CLINICAL EFFICACY AND SAFETY OF GRIPMAX NOS IN THE TREATMENT OF ACUTE RESPIRATORY INFECTIONS OF THE UPPER RESPIRATORY TRACT
10377 2 2024 10.34689/SH.2024.26.2.012 Background. The relevance of the study is due to the high prevalence of acute respiratory infections, which pose a significant threat to public health and require effective and safe treatment methods. A study of the efficacy and safety of Gripmax Nos as a monotherapy for such infections will help determine its potential to improve clinical outcomes and reduce the burden on the healthcare system. The aim of the study: To retrospectively evaluate the efficacy...
Изменен: 28.04.2024Путь: Главная / Home / Publications
Результаты поиска 1 1 из 1
Начало | Пред. | 1 | След. | Конец
Сортировать по релевантности | Отсортировано по дате